Salivary levels of tumor necrosis factor-α in oral lichen planus

Mediators of Inflammation

Volumn 13, Issue 2, 2004, Pages 131-133

  Pezelj Ribaric, Sonja ^a   Prso, Ivana Brekalo ^a   Abram, Maja ^a   Glazar, Irena ^a   Brumini, Gordana ^b   Simunovic Soskic, Marica ^c  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b University of Rijeka   (Croatia)

^c UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Oral lichen planus; Salivary levels; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; HUMAN; LICHEN PLANUS; PRIORITY JOURNAL; SALIVA; SALIVA ANALYSIS; SALIVA LEVEL;

DATA INTERPRETATION, STATISTICAL; HUMANS; LICHEN PLANUS, ORAL; SALIVA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2542526164     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350410001688530     Document Type: Article

References (15)

1. Mollaoglu N. Oral lichen planus: a review. Br J Oral Maxillofac Surg 2000; 38: 370-377.
2. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand 2001; 59: 174-177.
3. Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of interleukin-2, -4. -10, tumor necrosis factor-α and transforming growth factor-β mRNAs in oral lichen planus. Arch Oral Biol 1999; 44: 499-507.
4. Abram M, Vuckovic D, Wraber B, Doric M. Plasma cytokine response in mice with bacterial infection. Mediat Inflamm 2000; 9: 229-234.
5. Nakao S, Kuwano T, Ishibashi T, Kuwano M, Ono M. Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins. J Immunol 2003; 170: 5704-5711.
6. Gerstenfeld LC, Cho TJ, Kon T, et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 2003; 18: 1584-1592.
7. Scott KA, Moore RJ, Arnott CH, et al. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol Cancer Ther 2003; 2: 445-451.
8. Victor FC, Gottlieb AB. TNF-alpha and apoptosis: implications for the pathogenesis and treatment of psoriasis. J Drugs Dermatol 2002; 1: 264-275.
9. Simon M Jr, Gruschwitz MS. In situ expression and serum levels of tumour necrosis factor alpha receptors in patients with lichen planus. Acta Derm Venereol 1997; 77: 191-193.
10. Sugermann PB, Savage NW, Seymour GJ, Wals LJ. Is there a role for tumor necrosis factor-alpha (TNF-alpha) in oral lichen planus? J Oral Pathol Med 1996; 25: 219-224.
11. Yammamoto T, Yoneda K, Ueta E, Osaki T. Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg Oral Med Oral Pathol 1994; 78: 727-735.
12. Thornhil MH, Pemberton MN, Simmons RK, Theaker ED. Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 291-299.
13. Kawamura E, Nakamura S, Sasaki M, Ohyama Y, Kadena T, Kumamaru W, Shirasuna K. Accumulation of oligoclonal T cells in the infiltrating lymphocytes in oral lichen planus. J Oral Pathol Med 2003; 32: 282-289.
14. Rode M, Kogoj-Rode M. Malignant potential of teh reticular form of oral lichen planus over a 25-year observation period in 55 patients from Slovenia. J Oral Sci 2002; 44: 109-111.
15. Nagler RM, Hershkovich O, Lischinsky S, Diamond E, Reznick AZ. Saliva analysis in the clinical setting: revisiting an underused diagnostic tool. J Investig Med 2002; 50: 214-225.